The expression of OX40 in immunologically mediated diseases of the gastrointestinal tract (celiac disease, Crohn's disease, ulcerative colitis)

European Journal of Clinical Investigation

Volumn 30, Issue 7, 2000, Pages 594-599

  Stuber E ^a,b   Buschenfeld A ^a   Luttges J ^b   Von Freier, A ^a   Arendt, T ^a   Folsch U R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Celiac disease; Crohn's disease; OX40 expression; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBODY; ANTIGEN; BUFFER; CD4 ANTIGEN; CITRIC ACID; FORMALDEHYDE; MEMBRANE RECEPTOR; NERVE GROWTH FACTOR RECEPTOR; PARAFFIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELIAC DISEASE; CLINICAL ARTICLE; CROHN DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HUMAN TISSUE; IMMUNE MEDIATED INJURY; INTESTINE BIOPSY; LIGAND BINDING; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANTIGENS, CD27; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MALE; MIDDLE AGED; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0033923293     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00658.x     Document Type: Article

References (23)

1. 1 Podolski DK. Inflammatory bowel disease. N Engl J Med 1991;325:928-37.
2. 2 Marsh MN. Gluten, major histocompatibility complex, and the small intestine. Gastroenterol 1992;102:330-54.
3. 3 Möller G. Accessory molecules in the immune response. Immunol Rev 1996;153:1-223.
4. 4 Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 1994;76:959-62.
5. 5 Calderhead DM, Buhlmann JE, van der Eertwegh AJM, Claassen E, Noelle RJ, Fell HP. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B interactions. J Immunol 1993;151:5261-71.
6. 6 Baum PR, Gayle RB, Ramsdell F, Srinivasan S, Sörensen RA, Watson ML et al. Molecular characterizatíon of murine and human OX40/OX40L systems: identificatíon of a human OX40 ligand as HTLV-1 regulated protein gp-34. EMBO J 1994;13:3992-4001.
7. 7 Paterson DJ, Jefferies WA, Green JR, Brandon MR, Corthesy P, Puklavec M et al. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol 1987;24:1281-90.
8. + T cells with homology to tumor necrosis factor. J Exp Med 1994;180:757-62.
9. 9 Stüber E, Neurath M, Calderhead D, Fell HP, Strober W. Crosslinking of OX40-ligand, a member of the NGF/TNF family of cytokines, induces proliferation and differentiation in murine splenic B cells. Immunity 1995;2:507-21.
10. 10 Latza U, Dürkopf H, Schnittger S, Ringeling J, Eitelbach F, Hummel M et al. The human OX40 homolog: cDNA structure, expression and chromosomal assignement of the ACT35 antigen. Eur J Immunol 1994;24:267-83.
11. 11 Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997;159:3838-48.
12. 12 Stüber E, Strober W. The T cell - B cell interaction via OX40-OX40L is necessary for the T cell dependent humoral immune response. J Exp Med 1996;183:979-90.
13. 13 Weinberg A, Wallin J, Jones RE, Sullivan T, Bourdette DN, Vandenbark AA et al. Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA ba encephalogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J Immunol 1994;151:4712-21.
14. 14 Title T, Weinberg AD, Steinkeler CN, Maziars RT. Expression of the T-cell acivation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood 1997;89:4652-8.
15. 15 Weinberg A, Bourdette DN, Sullivan TJ, Lemon M, Wallin JJ, Maziarz R et al. Selective depletion of myelin-reactive T cells with the anti-OX40 antibody ameliorates autoimmune encephalomyelitis. Nat Med 1996;2:183-9.
16. 16 Higgins LM, MacDonald SAC, Shields JG, Timans J, Whittle N, MacDonald TT. An OX40 fusion protein prevents colitis in mice. Gastroenterology 1998;114:G4076.
17. 17 Stüber ER, Freier A, Marinescu D, Fölsch UR. Involvement of OX40-OX40L interactions in the intestinal manifestation of the murine acute Graft-versus-Host disease. Gastroenterology 1998;115:1205-15.
18. 18 Walker-Smith JA, Guandalini S, Schmitz J, Shmerlin DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990;65:909-11.
19. 19 Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
20. 20 Imura A, Hori T, Imada K, Kawamata S, Tanaka Y, Imamura S et al. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implications for the possible -involvement of OX40 in leukemic cell infiltrations. Blood 1997;89:2951-8.
21. 21 Dürkop H, Latza U, Himmelreich P, Stein U. Expression of the human OX40 (hOX40) antigen in normal and neoplastic tissues. Br J Haematol 1995;91:927-31.
22. 22 Brugnoni D, Bettinardi A, Mlalcarne F, Airo P, Cattaneo R. CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis. Br J Rheumatol 1998;37:584-5.
23. 23 Matsumura Y, Imura A, Hori T, Uchiyama T, Imamura S. Localizytion of OX40/gp34 in inflammatory skin diseases: a clue to elucidate the interaction between activated T cells and endothelial cells in infiltrations. Arch Dermatol Res 1997;289:653-6.